The natural YMDD mutations of hepatitis B virus in Western China

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 1, 2012, Pages 44-47

  Zhao, Jinrong ^a   Guo, Yanhai ^a   Yan, Zhen ^a   Liang, Ping ^a   Zhang, Ju ^a   Liu, Yonglan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene mutation; Hepatitis B virus; Lamivudine resistance; Pyrosequencing

Indexed keywords

HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NONHUMAN; PLASMID; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS MUTANT; VIRUS MUTATION;

ADOLESCENT; ADULT; CHILD; CHINA; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE;

EID: 84555177522     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.598871     Document Type: Article

References (14)

1. Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′- thiacytidine and related analogues. Proc Natl Acad Sci U S A 1991;88:8495-9. (Pubitemid 21915383)
2. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996;24:714-7. (Pubitemid 26296021)
3. Kobayashi S, Ide T, Sata M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J Hepatol 2001;34:584-6. (Pubitemid 32328516)
4. Akarsu M, Sengonul A, Tankurt E, Sayiner AA, Topalak O, Akpinar H, et al. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay. J Gastroenterol Hepatol 2006;21:1783-8. (Pubitemid 44656997)
5. Zhao JR, Bai YJ, Zhang QH, Wan Y, Li D, Yan XJ. Detection of hepatitis B virus DNA by real-time PCR using TaqMan-MGB probe technology. World J Gastroenterol 2005;11:508-10. (Pubitemid 40185584)
6. Zhao JR, Bai YJ, Wang Y, Zhang QH, Luo M, Yan XJ. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005;9: 328-32. (Pubitemid 40392951)
7. Zhao JR, Bai YJ, Zhang QH, Wang Y, Luo M, Yan XJ. Pyrosequencing- based approach for rapid detection of rifampinresistant Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2005;51:135-7. (Pubitemid 40215424)
8. Yoshida S, Hige S, Yoshida M, Yamashita N, Fujisawa S, Sato K, et al. Quantifi cation of lamivudine-resistant hepatitis B virus mutants by type-specifi c TaqMan minor groove binder probe assay in patients with chronic hepatitis B. Ann Clin Biochem 2008;45:59-64. (Pubitemid 351724615)
9. Lok AS, Zoulim F, Locarnini S, Mangia A, Niro G, Decraemer H, et al. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay. J Clin Microbiol 2002;40:3729-34.
10. Chen LY, Huang J, Zhang XP, Qiao P, Zhang W, Yang NM, et al. Clinical evaluation of oligonucleotide microarrays for the detection of HBV mutants associated with lamivudine resistance. Pharmacogenomics 2005;6:721-30. (Pubitemid 41479417)
11. Malmström S, Hannoun C, Lindh M. Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR. J Virol Methods 2007;143:147-52. (Pubitemid 46963385)
12. Lindström A, Odeberg J, Albert J. Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J Clin Microbiol 2004;42:4788-95. (Pubitemid 39362404)
13. Solmone M, Vincenti D, Prosperi MC, Bruselles A, Ippolito G, Capobianchi MR. Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J Virol 2009;83:1718-26.
14. Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, Wang C, et al. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis 2009;199: 1275-85.